110 related articles for article (PubMed ID: 9315002)
1. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
Delpassand ES; Jackson EF
Radiology; 1997 Oct; 205(1):283-4; author reply 285-6. PubMed ID: 9315002
[No Abstract] [Full Text] [Related]
2. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
Servais F; Blocklet DC; Seret AE; Lenaers A; Schoutens AC
Radiology; 1997 Oct; 205(1):283; author reply 285-6. PubMed ID: 9315001
[No Abstract] [Full Text] [Related]
3. Differentiation of benign and malignant breast lesions: MR imaging versus Tc-99m sestamibi scintimammography.
Helbich TH; Becherer A; Trattnig S; Leitha T; Kelkar P; Seifert M; Gnant M; Staudenherz A; Rudas M; Wolf G; Mostbeck GH
Radiology; 1997 Feb; 202(2):421-9. PubMed ID: 9015068
[TBL] [Abstract][Full Text] [Related]
4. Differentiation between benign and malignant breast lesions with MR imaging and scintimammography.
Khalkhali I
Radiology; 1997 Oct; 205(1):284-5; author reply 285-6. PubMed ID: 9315003
[No Abstract] [Full Text] [Related]
5. Benign versus malignant breast disease: comparison of contrast-enhanced MR imaging and Tc-99m tetrofosmin scintimammography.
Fenlon HM; Phelan NC; O'Sullivan P; Tierney S; Gorey T; Ennis JT
Radiology; 1997 Oct; 205(1):214-20. PubMed ID: 9314988
[TBL] [Abstract][Full Text] [Related]
6. Comparison of technetium-99m-sestamibi scintimammography with contrast-enhanced MRI for diagnosis of breast lesions.
Tiling R; Sommer H; Pechmann M; Moser R; Kress K; Pfluger T; Tatsch K; Hahn K
J Nucl Med; 1997 Jan; 38(1):58-62. PubMed ID: 8998151
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of mammographic breast lesions with Tc-99m sestamibi scintimammography and contrast enhanced MRI.
Sommer H; Tiling R; Pechmann M; Kindermann G; Kress K; Moser R; Tatsch K; Hahn K; Pfluger T; Assemi C
Zentralbl Gynakol; 1997; 119(1):6-11. PubMed ID: 9050197
[TBL] [Abstract][Full Text] [Related]
8. Scintimammography in breast cancer diagnosis.
Newman J
Radiol Technol; 1998; 70(2):153-68; quiz 169-72. PubMed ID: 9839329
[TBL] [Abstract][Full Text] [Related]
9. Impact of patient positioning in scintimammography.
Mirzaei S; Knoll P; Köhn H; Lipp RW; Zajicek SM
Eur J Nucl Med; 2001 Sep; 28(9):1437-8. PubMed ID: 11585308
[No Abstract] [Full Text] [Related]
10. Technetium-99m-sestamibi scintimammography of breast lesions: clinical and pathological follow-up.
Khalkhali I; Cutrone J; Mena I; Diggles L; Venegas R; Vargas H; Jackson B; Klein S
J Nucl Med; 1995 Oct; 36(10):1784-9. PubMed ID: 7562043
[TBL] [Abstract][Full Text] [Related]
11. Scintimammography: the complementary role of Tc-99m sestamibi prone breast imaging for the diagnosis of breast carcinoma.
Khalkhali I; Cutrone JA; Mena IG; Diggles LE; Venegas RJ; Vargas HI; Jackson BL; Khalkhali S; Moss JF; Klein SR
Radiology; 1995 Aug; 196(2):421-6. PubMed ID: 7617855
[TBL] [Abstract][Full Text] [Related]
12. Mammoscintigraphy with technetium-99m-sestamibi in suspected breast cancer.
Villanueva-Meyer J; Leonard MH; Briscoe E; Cesani F; Ali SA; Rhoden S; Hove M; Cowan D
J Nucl Med; 1996 Jun; 37(6):926-30. PubMed ID: 8683313
[TBL] [Abstract][Full Text] [Related]
13. [A Spanish multicenter scintigraphic study of the breast using Tc 99m MIBI. Report of results].
Prats E; Carril J; Herranz R; Meroño E; Banzo J; Gtemegmmt YE
Rev Esp Med Nucl; 1998; 17(5):338-50. PubMed ID: 9812008
[TBL] [Abstract][Full Text] [Related]
14. Scintimammography with Tc-99m sestamibi.
Khalkhali I; Iraniha S; Cutrone JA; Diggles LE; Klein SR
Acta Med Austriaca; 1997; 24(2):46-9. PubMed ID: 9227786
[TBL] [Abstract][Full Text] [Related]
15. Mammography and 99mTc-MIBI scintimammography in suspected breast cancer.
Prats E; Aisa F; Abós MD; Villavieja L; García-López F; Asenjo MJ; Razola P; Banzo J
J Nucl Med; 1999 Feb; 40(2):296-301. PubMed ID: 10025838
[TBL] [Abstract][Full Text] [Related]
16. Technetium-99m-sestamibi prone scintimammography to detect primary breast cancer and axillary lymph node involvement.
Taillefer R; Robidoux A; Lambert R; Turpin S; Laperrière J
J Nucl Med; 1995 Oct; 36(10):1758-65. PubMed ID: 7562039
[TBL] [Abstract][Full Text] [Related]
17. Scintimammography: the new role of technetium-99m Sestamibi imaging for the diagnosis of breast carcinoma.
Khalkhali I; Iraniha S; Diggles LE; Cutrone JA; Mishkin FS
Q J Nucl Med; 1997 Sep; 41(3):231-8. PubMed ID: 9274131
[TBL] [Abstract][Full Text] [Related]
18. Comparison of dynamic MR imaging of the breast and sestamibi scintimammography for evaluation of indeterminate mammographic lesions.
Leinsinger GL; Friedl L; Tiling R; Scherr MK; Heiss DT; Kandziora C; Camerer B; Sommer H; Pfluger T; Hahn K
Eur Radiol; 2001; 11(10):2050-7. PubMed ID: 11702141
[TBL] [Abstract][Full Text] [Related]
19. Technetium-99m-MIBI scintimammography in palpable and nonpalpable breast lesions.
Mekhmandarov S; Sandbank J; Cohen M; Lelcuk S; Lubin E
J Nucl Med; 1998 Jan; 39(1):86-91. PubMed ID: 9443742
[TBL] [Abstract][Full Text] [Related]
20. Tc-99m-MIBI scintimammography; SPECT versus planar imaging.
Aziz A; Hashmi R; Ogawa Y; Hayashi K
Cancer Biother Radiopharm; 1999 Dec; 14(6):495-500. PubMed ID: 10850336
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
